Suministro Farmacos 24 Horas 2
PROVEER DE MEDICAMENTOS A PACIENTES BENEFICIARIOS DEL HBSJO
22 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1063535-1588-SE22 | 29-07-2022 | Socofar S.A. | $35.986 |
| 1063535-1311-SE22 | 20-06-2022 | Synthon Chile Limitada | $774.690 |
| 1063535-928-SE22 | 06-05-2022 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-894-SE22 | 04-05-2022 | Socofar S.A. | $35.986 |
| 1063535-818-SE22 | 21-04-2022 | Exeltis Chile SpA | $1.567.373 |
| 1063535-772-SE22 | 13-04-2022 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-600-SE22 | 23-03-2022 | Synthon Chile Limitada | $774.690 |
| 1063535-563-SE22 | 11-03-2022 | Synthon Chile Limitada | $4.648.140 |
| 1063535-537-SE22 | 10-03-2022 | Socofar S.A. | $41.983 |
| 1063535-523-SE22 | 09-03-2022 | Novo Nordisk Farmaceutica Limitada | $173.740 |
| 1063535-517-SE22 | 09-03-2022 | Farmaceutica Insuval S.A. | $178.500 |
| 1063535-488-SE22 | 09-03-2022 | Laboratorios Recalcine S.A. | $492.660 |
| 1063535-428-SE22 | 01-03-2022 | Laboratorios Recalcine S.A. | $197.064 |
| 1063535-272-SE22 | 04-02-2022 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-267-SE22 | 02-02-2022 | Novo Nordisk Farmaceutica Limitada | $208.488 |
| 1063535-258-SE22 | 02-02-2022 | Socofar S.A. | $41.983 |
| 1063535-191-SE22 | 24-01-2022 | Synthon Chile Limitada | $774.690 |
| 1063535-168-SE22 | 24-01-2022 | Synthon Chile Limitada | $5.902.400 |
| 1063535-146-SE22 | 24-01-2022 | Synthon Chile Limitada | $1.549.380 |
| 1063535-142-SE22 | 24-01-2022 | Crisvert Limitada | $348.075 |
| 1063535-141-SE22 | 17-01-2022 | Grifols Chile S.A. | $214.164 |
| 1063535-47-SE22 | 05-01-2022 | Exeltis Chile SpA | $1.567.373 |
| 1063535-43-SE22 | 05-01-2022 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-2829-SE21 | 27-12-2021 | Synthon Chile Limitada | $774.690 |
| 1063535-2761-SE21 | 17-12-2021 | Synthon Chile Limitada | $3.098.760 |
| 1063535-2634-SE21 | 02-12-2021 | Exeltis Chile SpA | $1.279.488 |
| 1063535-2617-SE21 | 26-11-2021 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-2585-SE21 | 23-11-2021 | Synthon Chile Limitada | $3.098.760 |
| 1063535-2496-SE21 | 12-11-2021 | Crisvert Limitada | $232.050 |
| 1063535-2462-SE21 | 10-11-2021 | Exeltis Chile SpA | $1.919.232 |
| 1063535-2332-SE21 | 28-10-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-2328-SE21 | 28-10-2021 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-2267-SE21 | 27-10-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $120.522 |
| 1063535-2270-SE21 | 27-10-2021 | Synthon Chile Limitada | $774.690 |
| 1063535-2315-SE21 | 27-10-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-2018-SE21 | 14-10-2021 | Laboratorios Saval S.A. | $17.315 |
| 1063535-2096-SE21 | 14-10-2021 | Crisvert Limitada | $232.050 |
| 1063535-1973-SE21 | 24-09-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1912-SE21 | 23-09-2021 | Farmaceutica Insuval S.A. | $142.800 |
| 1063535-1920-SE21 | 14-09-2021 | Exeltis Chile SpA | $639.744 |
| 1063535-1938-SE21 | 14-09-2021 | Synthon Chile Limitada | $774.690 |
| 1063535-1787-SE21 | 13-09-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1760-SE21 | 07-09-2021 | Crisvert Limitada | $232.050 |
| 1063535-1726-SE21 | 07-09-2021 | Farmaceutica Insuval S.A. | $142.800 |
| 1063535-1739-SE21 | 31-08-2021 | Exeltis Chile SpA | $1.279.488 |
| 1063535-1592-SE21 | 09-08-2021 | Exeltis Chile SpA | $2.558.976 |
| 1063535-1577-SE21 | 04-08-2021 | Synthon Chile Limitada | $2.324.070 |
| 1063535-1518-SE21 | 29-07-2021 | Exeltis Chile SpA | $1.279.488 |
| 1063535-1502-SE21 | 28-07-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1482-SE21 | 27-07-2021 | Farmaceutica Insuval S.A. | $285.600 |
| 1063535-1490-SE21 | 27-07-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1456-SE21 | 27-07-2021 | Crisvert Limitada | $232.050 |
| 1063535-1436-SE21 | 19-07-2021 | Pfizer Chile S.A. | $14.726.250 |
| 1063535-1432-SE21 | 15-07-2021 | Pfizer Chile S.A. | $8.835.750 |
| 1063535-1227-SE21 | 25-06-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1216-SE21 | 25-06-2021 | Synthon Chile Limitada | $1.549.380 |
| 1063535-1200-SE21 | 23-06-2021 | Farmaceutica Insuval S.A. | $285.600 |
| 1063535-1130-SE21 | 14-06-2021 | Exeltis Chile SpA | $1.919.232 |
| 1063535-1104-SE21 | 09-06-2021 | Pfizer Chile S.A. | $5.890.500 |
| 1063535-1038-SE21 | 02-06-2021 | Crisvert Limitada | $232.050 |
| 1063535-993-SE21 | 27-05-2021 | Pfizer Chile S.A. | $5.890.500 |
| 1063535-950-SE21 | 20-05-2021 | Farmaceutica Insuval S.A. | $285.600 |
| 1063535-895-SE21 | 12-05-2021 | Laboratorios Andromaco S.A. | $621.180 |
| 1063535-848-SE21 | 04-05-2021 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-727-SE21 | 19-04-2021 | Farmaceutica Insuval S.A. | $238.000 |
| 1063535-709-SE21 | 15-04-2021 | Laboratorios Andromaco S.A. | $414.120 |
| 1063535-643-SE21 | 08-04-2021 | Novo Nordisk Farmaceutica Limitada | $173.740 |
| 1063535-617-SE21 | 06-04-2021 | Crisvert Limitada | $185.640 |
| 1063535-612-SE21 | 05-04-2021 | Exeltis Chile SpA | $1.580.168 |
| 1063535-600-SE21 | 31-03-2021 | Exeltis Chile SpA | $1.580.168 |
| 1063535-594-SE21 | 31-03-2021 | Laboratorios Andromaco S.A. | $207.060 |
| 1063535-528-SE21 | 23-03-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $34.415 |
| 1063535-502-SE21 | 18-03-2021 | Farmaceutica Insuval S.A. | $297.500 |
| 1063535-497-SE21 | 17-03-2021 | Pfizer Chile S.A. | $5.890.500 |
| 1063535-424-SE21 | 05-03-2021 | Laboratorios Andromaco S.A. | $207.060 |
| 1063535-384-SE21 | 02-03-2021 | Novo Nordisk Farmaceutica Limitada | $173.740 |
| 1063535-300-SE21 | 18-02-2021 | Laboratorios Biopas S.A. | $2.450.914 |
| 1063535-290-SE21 | 16-02-2021 | Farmaceutica Insuval S.A. | $249.900 |
| 1063535-261-SE21 | 11-02-2021 | Laboratorios Biopas S.A. | $1.225.457 |
| 1063535-229-SE21 | 08-02-2021 | Novo Nordisk Farmaceutica Limitada | $173.740 |
| 1063535-219-SE21 | 08-02-2021 | Crisvert Limitada | $185.640 |
| 1063535-66-SE21 | 15-01-2021 | Exeltis Chile SpA | $1.580.168 |
| 1063535-53-SE21 | 14-01-2021 | Crisvert Limitada | $185.640 |
| 1063535-44-SE21 | 13-01-2021 | Farmaceutica Insuval S.A. | $297.500 |
| 1063535-2032-SE20 | 30-12-2020 | Laboratorios Andromaco S.A. | $414.120 |
| 1063535-2039-SE20 | 22-12-2020 | Laboratorios Biopas S.A. | $1.838.186 |
| 1063535-1913-SE20 | 14-12-2020 | Crisvert Limitada | $185.640 |
| 1063535-1889-SE20 | 09-12-2020 | Synthon Chile Limitada | $5.422.830 |
| 1063535-1833-SE20 | 04-12-2020 | Farmaceutica Insuval S.A. | $297.500 |
| 1063535-1846-SE20 | 30-11-2020 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-1804-SE20 | 19-11-2020 | Synthon Chile Limitada | $3.873.450 |
| 1063535-1720-SE20 | 05-11-2020 | Novo Nordisk Farmaceutica Limitada | $277.984 |
| 1063535-1710-SE20 | 05-11-2020 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-1708-SE20 | 05-11-2020 | Synthon Chile Limitada | $3.873.450 |
| 1063535-1605-SE20 | 27-10-2020 | Farmaceutica Insuval S.A. | $315.350 |
| 1063535-1618-SE20 | 26-10-2020 | Synthon Chile Limitada | $3.098.760 |
| 1063535-1629-SE20 | 26-10-2020 | Crisvert Limitada | $185.640 |
| 1063535-1508-SE20 | 06-10-2020 | Synthon Chile Limitada | $3.098.760 |
| 1063535-1504-SE20 | 06-10-2020 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-1497-SE20 | 03-10-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-1443-SE20 | 23-09-2020 | Exeltis Chile SpA | $1.599.360 |
| 1063535-1370-SE20 | 17-09-2020 | Farmaceutica Insuval S.A. | $297.500 |
| 1063535-1400-SE20 | 12-09-2020 | Laboratorios Andromaco S.A. | $207.060 |
| 1063535-1349-SE20 | 09-09-2020 | Synthon Chile Limitada | $3.873.450 |
| 1063535-1327-SE20 | 08-09-2020 | Exeltis Chile SpA | $767.693 |
| 1063535-1318-SE20 | 02-09-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-1240-SE20 | 27-08-2020 | Crisvert Limitada | $185.640 |
| 1063535-1214-SE20 | 20-08-2020 | Exeltis Chile SpA | $511.795 |
| 1063535-1138-SE20 | 18-08-2020 | Farmaceutica Insuval S.A. | $357.000 |
| 1063535-1186-SE20 | 11-08-2020 | Synthon Chile Limitada | $3.873.450 |
| 1063535-1168-SE20 | 10-08-2020 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-1115-SE20 | 31-07-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-1045-SE20 | 17-07-2020 | Synthon Chile Limitada | $3.098.760 |
| 1063535-995-SE20 | 14-07-2020 | Crisvert Limitada | $150.833 |
| 1063535-985-SE20 | 04-07-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-976-SE20 | 04-07-2020 | Exeltis Chile SpA | $639.744 |
| 1063535-898-SE20 | 04-07-2020 | Pfizer Chile S.A. | $11.781.000 |
| 1063535-912-SE20 | 24-06-2020 | Laboratorios Andromaco S.A. | $310.590 |
| 1063535-878-SE20 | 16-06-2020 | Exeltis Chile SpA | $639.744 |
| 1063535-868-SE20 | 11-06-2020 | Synthon Chile Limitada | $3.873.450 |
| 1063535-799-SE20 | 09-06-2020 | Synthon Chile Limitada | $1.549.380 |
| 1063535-792-SE20 | 09-06-2020 | Laboratorios Andromaco S.A. | $103.530 |
| 1063535-789-SE20 | 05-06-2020 | Farmaceutica Insuval S.A. | $511.700 |
| 1063535-775-SE20 | 03-06-2020 | Pfizer Chile S.A. | $2.356.200 |
| 1063535-743-SE20 | 24-05-2020 | Synthon Chile Limitada | $1.549.380 |
| 1063535-722-SE20 | 14-05-2020 | Pfizer Chile S.A. | $9.424.800 |
| 1063535-713-SE20 | 13-05-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-690-SE20 | 08-05-2020 | Grifols Chile S.A. | $128.499 |
| 1063535-678-SE20 | 07-05-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-676-SE20 | 06-05-2020 | Exeltis Chile SpA | $639.744 |
| 1063535-673-SE20 | 05-05-2020 | Pfizer Chile S.A. | $14.726.250 |
| 1063535-659-SE20 | 30-04-2020 | Crisvert Limitada | $232.050 |
| 1063535-646-SE20 | 23-04-2020 | Exeltis Chile SpA | $479.808 |
| 1063535-627-SE20 | 18-04-2020 | Novo Nordisk Farmaceutica Limitada | $277.984 |
| 1063535-617-SE20 | 17-04-2020 | Pfizer Chile S.A. | $29.452.500 |
| 1063535-596-SE20 | 14-04-2020 | Synthon Chile Limitada | $1.549.380 |
| 1063535-598-SE20 | 14-04-2020 | Pfizer Chile S.A. | $11.781.000 |
| 1063535-577-SE20 | 04-04-2020 | Farmaceutica Insuval S.A. | $565.250 |
| 1063535-541-SE20 | 30-03-2020 | Crisvert Limitada | $232.050 |
| 1063535-538-SE20 | 29-03-2020 | Pfizer Chile S.A. | $2.356.200 |
| 1063535-539-SE20 | 29-03-2020 | Pfizer Chile S.A. | $3.534.300 |
| 1063535-532-SE20 | 27-03-2020 | Laboratorios Andromaco S.A. | $207.060 |
| 1063535-497-SE20 | 24-03-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-479-SE20 | 23-03-2020 | Laboratorios Recalcine S.A. | $328.440 |
| 1063535-468-SE20 | 19-03-2020 | Pfizer Chile S.A. | $1.178.100 |
| 1063535-422-SE20 | 18-03-2020 | Socofar S.A. | $59.976 |
| 1063535-419-SE20 | 16-03-2020 | Exeltis Chile SpA | $255.898 |
| 1063535-418-SE20 | 16-03-2020 | Novo Nordisk Farmaceutica Limitada | $138.992 |
| 1063535-412-SE20 | 16-03-2020 | Pfizer Chile S.A. | $2.356.200 |
| 1063535-405-SE20 | 13-03-2020 | Laboratorios Biopas S.A. | $9.190.929 |
| 1063535-397-SE20 | 12-03-2020 | Synthon Chile Limitada | $774.690 |
| 1063535-387-SE20 | 11-03-2020 | Farmaceutica Insuval S.A. | $377.825 |
| 1063535-320-SE20 | 02-03-2020 | Grifols Chile S.A. | $128.499 |
| 1063535-314-SE20 | 28-02-2020 | Synthon Chile Limitada | $1.549.380 |
| 1063535-312-SE20 | 28-02-2020 | Laboratorios Andromaco S.A. | $155.295 |
| 1063535-283-SE20 | 26-02-2020 | Laboratorios Recalcine S.A. | $229.908 |
Fuente original:ficha mercadopublico.cl
